Application 040653
- Type
- ANDA
- Sponsor
- PAR PHARM
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GLYCOPYRROLATE | GLYCOPYRROLATE | TABLET;ORAL | 1MG | No | Yes |
| 002 | GLYCOPYRROLATE | GLYCOPYRROLATE | TABLET;ORAL | 2MG | No | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A040653-001 | GLYCOPYRROLATE | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | RS | 2006-08-31 |
| A040653-002 | GLYCOPYRROLATE | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | RS | 2006-08-31 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A040653-001 | AA |
| A040653-002 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A040653-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | RS | 2006-08-31 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A040653-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | RS | 2006-08-31 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A040653-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | RS | 2006-08-31 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A040653-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | RS | 2006-08-31 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A040653-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | RS | 2006-08-31 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A040653-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | RS | 2006-08-31 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A040653-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | RS | 2006-08-31 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A040653-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | RS | 2006-08-31 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A040653-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | RS | 2006-08-31 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A040653-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | RS | 2006-08-31 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A040653-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | RS | 2006-08-31 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A040653-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | RS | 2006-08-31 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A040653-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | RS | 2006-08-31 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A040653-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | RS | 2006-08-31 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A040653-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | RS | 2006-08-31 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A040653-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | RS | 2006-08-31 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A040653-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | RS | 2006-08-31 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A040653-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | RS | 2006-08-31 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A040653-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | RS | 2006-08-31 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A040653-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | RS | 2006-08-31 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A040653-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | RS | 2006-08-31 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A040653-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | RS | 2006-08-31 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A040653-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | RS | 2006-08-31 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A040653-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | RS | 2006-08-31 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A040653-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | RS | 2006-08-31 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A040653-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | RS | 2006-08-31 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A040653-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | RS | 2006-08-31 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A040653-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | RS | 2006-08-31 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A040653-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | RS | 2006-08-31 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A040653-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | RS | 2006-08-31 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A040653-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | RS | 2006-08-31 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A040653-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | RS | 2006-08-31 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A040653-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | RS | 2006-08-31 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A040653-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | RS | 2006-08-31 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A040653-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | RS | 2006-08-31 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A040653-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | RS | 2006-08-31 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A040653-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | RS | 2006-08-31 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A040653-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | RS | 2006-08-31 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A040653-001 | GLYCOPYRROLATE | 1MG | TABLET / ORAL | AA | RS | 2006-08-31 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A040653-002 | GLYCOPYRROLATE | 2MG | TABLET / ORAL | AA | RS | 2006-08-31 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A040653-001 | AA | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A040653-002 | AA | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycopyrrolate | GLYCOPYRROLATE | Par Health USA, LLC | 1f266d77-4f9e-44c9-a000-2f8fea3ac80b | 2026-07-09 | Warnings, Adverse reactions | 040653 ANDA040653 49884-066 49884-065 |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | d93a9b2b-708d-4db5-8aae-45fd3a7ca65c | 2025-01-06 | Warnings, Adverse reactions | 040653 ANDA040653 |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | f7187ddb-ea11-4aa8-8215-a5fcf0f1ca7c | 2024-10-09 | Warnings, Adverse reactions | 040653 ANDA040653 63629-2206 |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | 987ba524-361e-49c3-9e00-550a78748542 | 2024-10-09 | Warnings, Adverse reactions | 040653 ANDA040653 63629-2207 |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | 48a8356e-377e-45ef-a1bf-e9ffec051749 | 2024-10-08 | Warnings, Adverse reactions | 040653 ANDA040653 63629-9287 |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | fcb295e4-038f-4d4f-8786-4fbcd1d3c298 | 2024-10-04 | Warnings, Adverse reactions | 040653 ANDA040653 71335-2119 |
| Glycopyrrolate | GLYCOPYRROLATE | Bryant Ranch Prepack | 33bbc475-2fe3-48ab-8a9d-56d13053593e | 2024-10-04 | Warnings, Adverse reactions | 040653 ANDA040653 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0615-8170 | Glycopyrrolate | glycopyrrolate | NCS HealthCare of KY, Inc dba Vangard Labs | ANDA | Current |
| 0615-8170 | Glycopyrrolate | glycopyrrolate | NCS HealthCare of KY, Inc dba Vangard Labs | ANDA | Current |
| 43227-065 | Glycopyrrolate | Glycopyrrolate | Par Formulations Private Limited | ANDA | Current |
| 43227-066 | Glycopyrrolate | Glycopyrrolate | Par Formulations Private Limited | ANDA | Current |
| 49884-065 | Glycopyrrolate | glycopyrrolate | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-066 | Glycopyrrolate | glycopyrrolate | Par Pharmaceutical, Inc. | ANDA | Current |
| 60687-270 | Glycopyrrolate | glycopyrrolate | American Health Packaging | ANDA | Current |
| 63629-2206 | Glycopyrrolate | glycopyrrolate | Bryant Ranch Prepack | ANDA | Current |
| 63629-2206 | Glycopyrrolate | glycopyrrolate | Bryant Ranch Prepack | ANDA | Current |
| 63629-2207 | Glycopyrrolate | glycopyrrolate | Bryant Ranch Prepack | ANDA | Current |
| 63629-2207 | Glycopyrrolate | glycopyrrolate | Bryant Ranch Prepack | ANDA | Current |
| 63629-5442 | Glycopyrrolate | glycopyrrolate | Bryant Ranch Prepack | ANDA | Current |
| 63629-9287 | Glycopyrrolate | glycopyrrolate | Bryant Ranch Prepack | ANDA | Current |
| 64980-272 | Glycopyrrolate | glycopyrrolate | Rising Pharmaceuticals, Inc. | ANDA | Current |
| 64980-273 | Glycopyrrolate | glycopyrrolate | Rising Pharmaceuticals, Inc. | ANDA | Current |
| 71335-2119 | Glycopyrrolate | glycopyrrolate | Bryant Ranch Prepack | ANDA | Current |